The investment comes as biotechnology takes on a growing role in pharmaceutical manufacturing, offering new ways to produce complex molecules through advanced fermentation processes
Collaboration combines VIT’s research capabilities with Fermenta’s expertise in vitamins, nutritional premixes and food fortification
Merida's lead drug candidate, MER511, is already being tested in a Phase 1 trial for Graves' disease and thyroid eye disease
Researchers, clinicians, startups and industry leaders discuss applications spanning diagnostics, biomedical imaging, drug discovery and precision medicine at National Conference on Quantum Biotechnology
Celvivo’s ClinoStar platform is designed to produce relevant, abundant, reproducible and easy-to-use 3D cell cultures
MabGenesis, based in Yokohama, Kanagawa, is focused on developing therapeutic monoclonal antibodies
GSDIa is caused by pathogenic variants in the G6PC gene
The partnership will use community engagement, education and personal stories to spotlight the realities of living with sickle cell disease and help patients
Eclipsebio’s platform is designed to optimize RNA for both manufacturability and efficacy
The biodefense company is calling for deeper collaboration among governments, industry, academia and the scientific community
Effective August 4, 2026, 2,94,30,987 equity shares of face value Rs. 5 each have been listed and admitted to trading on the NSE
Telangana Life Sciences, BITS Pilani and RMIT Australia launch industry-integrated PhD programme for life sciences
GenomeIndia, Bio-AI Hubs, IBDC and ANRF-led initiatives strengthen India's AI-enabled biotechnology ecosystem with focus on healthcare, biomanufacturing and translational research
National programme aims to accelerate development of bio-butanol technologies for India's clean energy and industrial transition
The partnership gives the German pharmaceutical company access to one of the country's leading academic and biotech networks focused on nucleic acid therapeutics
With new distribution agreements in Argentina, Hong Kong & Singapore
Lilly will also gain VLS-01, a buccal film formulation of DMT currently in Phase 2b testing, along with AtaiBeckley's broader pipeline of next-generation neuroplastogens aimed at restoring the brain's ability to form new neural connections
The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
Subscribe To Our Newsletter & Stay Updated
